TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 78 filers reported holding TANGO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $303,581 | +337212.2% | 26,961 | 0.0% | 0.20% | +195.5% |
| Q2 2023 | $90 | -99.9% | 26,961 | 0.0% | 0.07% | -10.8% |
| Q1 2023 | $106,496 | -45.5% | 26,961 | 0.0% | 0.07% | -33.9% |
| Q4 2022 | $195,467 | +99.5% | 26,961 | 0.0% | 0.11% | +220.0% |
| Q3 2022 | $98,000 | -19.7% | 26,961 | 0.0% | 0.04% | -20.5% |
| Q2 2022 | $122,000 | -40.2% | 26,961 | 0.0% | 0.04% | -18.5% |
| Q1 2022 | $204,000 | -30.8% | 26,961 | 0.0% | 0.05% | +12.5% |
| Q4 2021 | $295,000 | -15.5% | 26,961 | 0.0% | 0.05% | -2.0% |
| Q3 2021 | $349,000 | – | 26,961 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $87,719,000 | 57.68% |
| TCG Crossover Management, LLC | 1,172,250 | $5,310,000 | 2.26% |
| Boxer Capital, LLC | 6,871,642 | $31,129,000 | 1.97% |
| Cormorant Asset Management, LP | 4,507,843 | $20,421,000 | 1.54% |
| Casdin Capital, LLC | 3,500,000 | $15,855,000 | 1.34% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $8,706,000 | 1.02% |
| Samsara BioCapital, LLC | 630,000 | $2,854,000 | 0.76% |
| Southpoint Capital Advisors LP | 4,500,000 | $20,385,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 708,385 | $3,209,000 | 0.37% |
| EcoR1 Capital, LLC | 2,302,065 | $10,428,000 | 0.36% |